000 | 01200 a2200337 4500 | ||
---|---|---|---|
005 | 20250512083838.0 | ||
264 | 0 | _c19850917 | |
008 | 198509s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbernethy, D R | |
245 | 0 | 0 |
_aProbenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cAug 1985 |
||
300 |
_a345-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAcetaminophen _xmetabolism |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucuronates _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLorazepam _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Clearance Rate _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProbenecid _xpharmacology |
700 | 1 | _aGreenblatt, D J | |
700 | 1 | _aAmeer, B | |
700 | 1 | _aShader, R I | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 234 _gno. 2 _gp. 345-9 |
|
999 |
_c4026359 _d4026359 |